Breast cancer market report is segmented based on type, treatment, end-user, and by regional & country level. The breast Cancer Market is valued at USD 18.40 Billion in 2018 and is expected to reach USD 37.47 Billion by 2025 with a CAGR of 10.7% over the forecast period.

Breast Cancer Drugs Market Size, Share & Trends Analysis Report: The global breast cancer drugs market size was valued at USD 16.98 billion in 2017 and is expected to register at a CAGR of 10.7% over the forecast period. The rising prevalence of the disease along with emerging novel therapies are some of the major factors likely to drive the market.

Recent Developments:

• On 09-Apr-2021 the FDA has approved several targeted therapies to treat HER2-positive breast cancer, including Trastuzumab (Herceptin) and pertuzumab (Perjeta) can be used in combination with chemotherapy for both early and advanced breast cancer.
• In 2019, the immunotherapy drug Atezolizumab (Tecentriq), was approved along with the chemotherapy drug nab-paclitaxel (Abraxane) for use in women with advanced triple-negative breast cancer that makes the PD-L1 protein.
  Source: https://www.grandviewresearch.com/industry-analysis/breast-cancer-drugs-market